-
A poor working relationship with the compliance officer can lead to more than just frustration and the occasional argument, cautions George B. Breen, JD, an attorney with the law firm of Epstein Becker Green in New York City. It also could lead to substantial liability for the healthcare provider.
-
As the January 2012 deadline for hospitals to convert to HIPAA Version 5010 quickly approaches, a survey conducted by the Medical Group Management Association (MGMA) has found that medical practices are lagging in the race to meet 5010 deadlines. In fact, 45.2% of practices report that they have not yet started implementation or software upgrades.
-
A good working relationship with the compliance officer will not only avoid squabbles over turf but actually enhance the productivity of both offices, says Timothy E.J. Folk, a producer with The Graham Co., a healthcare consulting company in Philadelphia.
-
-
Measurement of biomarkers, including Ab42 and tau protein in the CSF along with volumetric measurements of the hippocampus, may help in the diagnosis of early or presymptomatic Alzheimer's disease.
-
-
Apixaban could soon join the anticoagulation market; Chinese herbs for flu; chronic medication and discontinuation after hospitalization; and FDA actions.
-
Extended-release pramipexole is effective in both early and advanced Parkinson's disease, with a safety and tolerability profile similar to that of immediate-release pramipexole.
-
Amyloidosis may present with the clinical and electrophysiologic features of chronic inflammatory demyelinating polyneuropathy. Nerve biopsy may be necessary to make an accurate diagnosis.
-
Sleep-disordered breathing is a significant risk factor for cognitive decline and continuous positive airway pressure (CPAP) therapy may prevent or slow this process.